Development of a method to quantify total and free irinotecan and 7-ethyl-10-hydroxycamptothecin (SN-38) for pharmacokinetic and bio-distribution studies after administration of irinotecan liposomal formulation-Reference-Cited by-同舟云学术

Development of a method to quantify total and free irinotecan and 7-ethyl-10-hydroxycamptothecin (SN-38) for pharmacokinetic and bio-distribution studies after administration of irinotecan liposomal formulation

Published:2019-11 Issue:6 Volume:14 Page:687-697
ISSN:1818-0876
Container-title:Asian Journal of Pharmaceutical Sciences
language:en
Short-container-title:Asian Journal of Pharmaceutical Sciences

Author:

Yang Wenqian,Yang Zimeng,Liu Jieru,Liu Dan,Wang Yongjun

Publisher

Elsevier BV

Subject

Pharmaceutical Science,Pharmacology

Reference24 articles.

1. Liposomal drug delivery systems: from concept to clinical applications;Allen;Adv Drug Deliv Rev,2013

2. The safety and efficacy of Onivyde (irinotecan liposome injection) for the treatment of metastatic pancreatic cancer following gemcitabine-based therapy;Passero;Expert Rev Anticancer Ther,2016

3. Development of a highly active nanoliposomal irinotecan using a novel intraliposomal stabilization strategy;Drummond;Cancer Res,2006

4. Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer;Charrois;Biochim Biophys Acta,2004

5. Determination of free and liposome-associated doxorubicin and vincristine levels in plasma under equilibrium conditions employing ultrafiltration techniques;Mayer;Anal Biochem,1995

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative determination of liposomal irinotecan and SN-38 concentrations in plasma samples from children with solid tumors: Use of a cryoprotectant solution to enhance liposome stability;Journal of Chromatography B;2024-09

2. A validated high‐performance liquid chromatography‐tandem mass spectrometry method for simultaneous determination of irinotecan and two major metabolites in rat plasma: Application for the pharmacokinetics study;SEPARATION SCIENCE PLUS;2024-05-10

3. IRINOTECAN-REVIEW OF ANALYTICAL METHODS DEVELOPED FOR PHARMACEUTICAL DOSAGE FORMS AND BIOLOGICAL FLUIDS;International Journal of Applied Pharmaceutics;2023-11-07

4. Fluorescence Lifetime Nanoscopy of Liposomal Irinotecan Onivyde: From Manufacturing to Intracellular Processing;ACS Applied Bio Materials;2023-09-12

5. Fine-tuning the structure-tolerance-antitumor efficacy axis of prodrug nanoassemblies via branched aliphatic functionalization;Nano Research;2023-08-30